PL4012023T3 - Terapia komórkami macierzystymi w patologiach endometrium - Google Patents
Terapia komórkami macierzystymi w patologiach endometriumInfo
- Publication number
- PL4012023T3 PL4012023T3 PL22150013.5T PL22150013T PL4012023T3 PL 4012023 T3 PL4012023 T3 PL 4012023T3 PL 22150013 T PL22150013 T PL 22150013T PL 4012023 T3 PL4012023 T3 PL 4012023T3
- Authority
- PL
- Poland
- Prior art keywords
- stem cell
- cell therapy
- endometrial
- pathologies
- endometrial pathologies
- Prior art date
Links
- 230000002357 endometrial effect Effects 0.000 title 1
- 230000007170 pathology Effects 0.000 title 1
- 238000009168 stem cell therapy Methods 0.000 title 1
- 238000009580 stem-cell therapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462013121P | 2014-06-17 | 2014-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4012023T3 true PL4012023T3 (pl) | 2024-09-02 |
Family
ID=54329860
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22150013.5T PL4012023T3 (pl) | 2014-06-17 | 2015-06-05 | Terapia komórkami macierzystymi w patologiach endometrium |
| PL19169309T PL3569697T3 (pl) | 2014-06-17 | 2015-06-05 | Terapia komórkami macierzystymi w patologiach endometrium |
| PL15781411T PL3158057T3 (pl) | 2014-06-17 | 2015-06-05 | Terapia komórkami macierzystymi w patologiach endometrium |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19169309T PL3569697T3 (pl) | 2014-06-17 | 2015-06-05 | Terapia komórkami macierzystymi w patologiach endometrium |
| PL15781411T PL3158057T3 (pl) | 2014-06-17 | 2015-06-05 | Terapia komórkami macierzystymi w patologiach endometrium |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US11129851B2 (enExample) |
| EP (3) | EP4012023B1 (enExample) |
| JP (2) | JP6920062B2 (enExample) |
| CN (2) | CN116747241A (enExample) |
| AU (1) | AU2015275798B2 (enExample) |
| BR (1) | BR112016029558A2 (enExample) |
| CA (1) | CA2952559C (enExample) |
| CY (2) | CY1122615T1 (enExample) |
| DK (2) | DK3158057T3 (enExample) |
| ES (3) | ES2736117T3 (enExample) |
| HR (3) | HRP20191240T1 (enExample) |
| HU (3) | HUE067463T2 (enExample) |
| LT (2) | LT3569697T (enExample) |
| MX (1) | MX377300B (enExample) |
| PL (3) | PL4012023T3 (enExample) |
| PT (2) | PT3569697T (enExample) |
| RS (3) | RS63093B1 (enExample) |
| RU (1) | RU2725006C2 (enExample) |
| SI (2) | SI3158057T1 (enExample) |
| SM (3) | SMT202400270T1 (enExample) |
| TR (1) | TR201910410T4 (enExample) |
| WO (1) | WO2015193737A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| BR112014030750A2 (pt) | 2012-06-06 | 2017-08-22 | Inst Catalana Recerca Estudis Avancats | Método para diagnóstico, prognóstico e tratamento da metástase do câncer pulmonar |
| US10119171B2 (en) | 2012-10-12 | 2018-11-06 | Inbiomotion S.L. | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis |
| ES2906586T3 (es) | 2012-10-12 | 2022-04-19 | Inbiomotion Sl | Método para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de próstata |
| WO2014140896A2 (es) | 2013-03-15 | 2014-09-18 | Fundacio Privada Institut De Recerca Biomedica | Metodo para el diagnostico, pronostico y tratamiento de la metastasis de un cancer |
| JP6920062B2 (ja) | 2014-06-17 | 2021-08-18 | アイジェノミクス エセ．エレ． | 子宮内膜病変における幹細胞治療 |
| KR20190029587A (ko) * | 2016-06-23 | 2019-03-20 | 티톤 바이오테크, 인크. | 부갑상선 호르몬 1 수용체를 발현하는 세포 및 그의 용도 |
| RU2699029C1 (ru) * | 2018-12-10 | 2019-09-03 | Частное образовательное учреждение дополнительного профессионального образования "Академия медицинского образования имени Федора Ивановича Иноземцева" (ЧОУ ДПО "Академия медицинского образования им. Ф.И. Иноземцева") | Способ использования мезенхимальных стволовых клеток для улучшения состояния рубца на матке |
| RU2741621C1 (ru) * | 2020-09-25 | 2021-01-28 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации | Способ лечения внутриматочных синехий |
| CN117979980A (zh) | 2021-07-23 | 2024-05-03 | 车医科学大学校产学协力团 | 用于预防或治疗阿谢曼综合征的包含分离的线粒体作为活性成分的药物组合物 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990013299A1 (en) | 1989-05-05 | 1990-11-15 | Northern Sydney Area Health Service | Fertility enhancement |
| US6979533B2 (en) | 1992-06-12 | 2005-12-27 | The Trustees Of The University Of Pennsylvania | Determination of endometrial receptivity toward embryo implantation |
| CA2203718A1 (en) | 1997-04-25 | 1998-10-25 | University Of British Columbia | Cadherin-11 as an indicator of viable pregnancy |
| IL127896A0 (en) | 1998-12-31 | 1999-10-28 | Gail Laster | A novel treatment for preeclampsia and related diseases |
| IL151265A0 (en) | 2000-03-08 | 2003-04-10 | Kliman Harvey J | Methods of diagnosing and monitoring endometrial glandular development |
| EP1301195A2 (en) | 2000-05-24 | 2003-04-16 | Schering Aktiengesellschaft | Pharmaceutical use of fibulin-1 |
| US6780594B2 (en) | 2000-09-25 | 2004-08-24 | Schering Aktiengesellschaft | Method for in vitro diagnosis of endometriosis |
| AUPR673001A0 (en) | 2001-07-31 | 2001-08-23 | Prince Henry's Institute Of Medical Research | Pregnancy-related enzyme activity |
| DE10139874A1 (de) | 2001-08-10 | 2003-04-30 | Schering Ag | Humane Mater-Proteine |
| GB0201284D0 (en) | 2002-01-21 | 2002-03-06 | Isis Innovation | Screening methods for contraceptive and fertility agents |
| US20030186300A1 (en) | 2002-03-20 | 2003-10-02 | Ali Akoum | Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment of related conditions |
| CA2489568A1 (en) | 2002-05-14 | 2004-07-22 | The Board Of Trustees Of The Leland Stanford Junior University | Endometrial genes in endometrial disorders |
| WO2004014935A1 (de) | 2002-08-02 | 2004-02-19 | Schering Aktiengesellschaft | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie |
| DE10236405A1 (de) | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
| DE10361928A1 (de) | 2002-12-21 | 2004-07-01 | Universität Leipzig | Verfahren und Mittel zur Bestimmung von bestimmten Zuständen bzw. Veränderungen im Uterusepithel und im Epithel anderer Organe |
| EP1660228A1 (en) | 2003-08-21 | 2006-05-31 | PamGene B.V. | Microarray support for bioprobe synthesis |
| JP2007504807A (ja) | 2003-09-08 | 2007-03-08 | ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | 培養培地にプロスタグランジン又はプロスタグランジン類似物を補足することによってインビトロ胚発生を高めるための方法及び組成 |
| WO2005026324A2 (en) | 2003-09-08 | 2005-03-24 | The Board Of Regents Of The University Of Texas System | Method and composition for enhancing in vitro embryo development by supplementing culture medium with prostaglandin or a prostaglandin analog |
| EP1711618B1 (en) | 2003-12-23 | 2010-08-04 | Mount Sinai Hospital Corporation | Methods for detecting markers associated with endometrial disease or phase |
| CA2565801A1 (en) | 2004-05-28 | 2005-12-15 | Applied Research Systems Ars Holding N.V. | Use of il-17 in the treatment of fertility-related disorders |
| RU2434645C2 (ru) * | 2006-03-31 | 2011-11-27 | Конинклейке Филипс Электроникс, Н.В. | Системы и методы измерения клеток, использующие ультракороткую т2*-релаксометрию |
| JP2007278750A (ja) | 2006-04-04 | 2007-10-25 | Ono Pharmaceut Co Ltd | プロスタグランジン類及びその類縁体の定量方法 |
| WO2008036374A2 (en) * | 2006-09-21 | 2008-03-27 | Medistem Laboratories, Inc. | Allogeneic stem cell transplants in non-conditioned recipients |
| GB0703683D0 (en) * | 2007-02-26 | 2007-04-04 | Ark Therapeutics Ltd | The treatment of complications in pregnancy |
| US9259233B2 (en) * | 2007-04-06 | 2016-02-16 | Hologic, Inc. | Method and device for distending a gynecological cavity |
| WO2009143633A1 (en) | 2008-05-30 | 2009-12-03 | Institut De Recherches Cliniques De Montreal | Pcsk9 inhibitors and methods of use thereof |
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| WO2013166281A1 (en) * | 2012-05-02 | 2013-11-07 | Cedars-Sinai Medical Center | Bi-functional compositions for targeting cells to diseased tissues and methods of using same |
| EP2348318A1 (en) | 2010-01-21 | 2011-07-27 | Equipo Ivi Investigación, S.L. | Diagnostic method for endometrial receptivity |
| JP6204919B2 (ja) | 2011-10-21 | 2017-09-27 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 調節性過排卵誘起後の患者の子宮内膜受容性を評価するための方法 |
| AU2012346594B2 (en) | 2011-11-30 | 2017-12-21 | Agency For Science, Technology And Research | GM1 ganglioside to Annexin V microparticle polypeptide ratio for biological monitoring |
| BR112014029233A8 (pt) | 2012-06-27 | 2019-01-29 | Hoffmann La Roche | método para diagnosticar se um indivíduo grávido não está em risco, usos de pelo menos um dos biomarcadores sfit-1, endoglina e pigf, dispositivo, kit, método de gestão de um indivíduo, sistema e método para estabelecer um auxílio |
| RU2515475C1 (ru) * | 2012-11-15 | 2014-05-10 | Федеральное государственное бюджетное учреждение науки ИНСТИТУТ ЦИТОЛОГИИ РОССИЙСКОЙ АКАДЕМИИ НАУК | Способ стимуляции образования децидуальной оболочки эндометрия в эксперименте |
| EP3120152A2 (en) | 2014-03-21 | 2017-01-25 | Igenomix S.L. | Early detection of preeclampsia |
| JP6920062B2 (ja) | 2014-06-17 | 2021-08-18 | アイジェノミクス エセ．エレ． | 子宮内膜病変における幹細胞治療 |
-
2015
- 2015-06-05 JP JP2016573587A patent/JP6920062B2/ja active Active
- 2015-06-05 LT LTEP19169309.2T patent/LT3569697T/lt unknown
- 2015-06-05 HU HUE22150013A patent/HUE067463T2/hu unknown
- 2015-06-05 HR HRP20191240 patent/HRP20191240T1/hr unknown
- 2015-06-05 BR BR112016029558A patent/BR112016029558A2/pt not_active Application Discontinuation
- 2015-06-05 ES ES15781411T patent/ES2736117T3/es active Active
- 2015-06-05 RS RS20220339A patent/RS63093B1/sr unknown
- 2015-06-05 CN CN202310575540.1A patent/CN116747241A/zh active Pending
- 2015-06-05 EP EP22150013.5A patent/EP4012023B1/en active Active
- 2015-06-05 SI SI201530822T patent/SI3158057T1/sl unknown
- 2015-06-05 PL PL22150013.5T patent/PL4012023T3/pl unknown
- 2015-06-05 ES ES19169309T patent/ES2910306T3/es active Active
- 2015-06-05 HU HUE15781411 patent/HUE044823T2/hu unknown
- 2015-06-05 LT LTEP15781411.2T patent/LT3158057T/lt unknown
- 2015-06-05 AU AU2015275798A patent/AU2015275798B2/en active Active
- 2015-06-05 PL PL19169309T patent/PL3569697T3/pl unknown
- 2015-06-05 SI SI201531822T patent/SI3569697T1/sl unknown
- 2015-06-05 HR HRP20240798TT patent/HRP20240798T1/hr unknown
- 2015-06-05 EP EP19169309.2A patent/EP3569697B8/en active Active
- 2015-06-05 RS RSP20190913 patent/RS59210B1/sr unknown
- 2015-06-05 ES ES22150013T patent/ES2983444T3/es active Active
- 2015-06-05 SM SM20240270T patent/SMT202400270T1/it unknown
- 2015-06-05 DK DK15781411.2T patent/DK3158057T3/da active
- 2015-06-05 RS RS20240690A patent/RS65719B1/sr unknown
- 2015-06-05 TR TR2019/10410T patent/TR201910410T4/tr unknown
- 2015-06-05 PT PT191693092T patent/PT3569697T/pt unknown
- 2015-06-05 US US15/318,825 patent/US11129851B2/en active Active
- 2015-06-05 MX MX2016016756A patent/MX377300B/es active IP Right Grant
- 2015-06-05 DK DK19169309.2T patent/DK3569697T3/da active
- 2015-06-05 SM SM20220155T patent/SMT202200155T1/it unknown
- 2015-06-05 CN CN201580043147.1A patent/CN107073040A/zh active Pending
- 2015-06-05 PT PT15781411T patent/PT3158057T/pt unknown
- 2015-06-05 PL PL15781411T patent/PL3158057T3/pl unknown
- 2015-06-05 WO PCT/IB2015/001715 patent/WO2015193737A1/en not_active Ceased
- 2015-06-05 EP EP15781411.2A patent/EP3158057B1/en active Active
- 2015-06-05 SM SM20190400T patent/SMT201900400T1/it unknown
- 2015-06-05 CA CA2952559A patent/CA2952559C/en active Active
- 2015-06-05 RU RU2017101147A patent/RU2725006C2/ru active
- 2015-06-05 HU HUE19169309A patent/HUE058328T2/hu unknown
- 2015-06-05 HR HRP20220419TT patent/HRP20220419T1/hr unknown
-
2019
- 2019-07-16 CY CY20191100753T patent/CY1122615T1/el unknown
-
2020
- 2020-06-12 JP JP2020102340A patent/JP2020138984A/ja active Pending
-
2022
- 2022-04-05 CY CY20221100258T patent/CY1125938T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274903A (en) | cell | |
| GB201507368D0 (en) | Cell | |
| SMT202400270T1 (it) | Terapia con cellule staminali in patologie endometriali | |
| PL3134724T3 (pl) | Komórka elektrochemiczna | |
| SG10202000644TA (en) | Improved Stem Cell Composition | |
| SG11201610831PA (en) | Lithium-sulphur battery | |
| PL3157504T3 (pl) | Kompozycje stymulujące komórki macierzyste | |
| SG10202004286UA (en) | Integrated single cell sequencing | |
| GB201411985D0 (en) | Battery | |
| SG10201604600XA (en) | Low hydrogen-based covered electrode | |
| PL3149792T3 (pl) | Ogniwo litowo-siarkowe | |
| SG10201403640XA (en) | Stem cells | |
| GB201406700D0 (en) | Cervix cells | |
| GB201416493D0 (en) | Polypeptides for use in therapy | |
| GB201416750D0 (en) | Cell preparation | |
| ZA201505928B (en) | Built in gas-fired braii unit | |
| GB201406606D0 (en) | Improvements in transformer design | |
| GB201411798D0 (en) | Electrochemical cell | |
| GB201410934D0 (en) | T cell |